SECsense Logo

Bicycle Therapeutics plc 8-K Report: Key Financial Insights as of January 13, 2025

$BCYC
Form 8-K
Filed on: 2025-01-13
Source
Bicycle Therapeutics plc 8-K Report: Key Financial Insights as of January 13, 2025

Based on the provided XML data from the financial report, here are the key pieces of information extracted:

  1. Company Identification:
  • Entity Name: Bicycle Therapeutics plc
  • SEC CIK Number: 0001761612
  • Reporting Date: January 13, 2025
  1. Stock Information:
  • Ordinary Shares:
    • Nominal Value: £0.01 per share
  • American Depositary Shares (ADS):
    • Each ADS represents one ordinary share with the same nominal value of £0.01.
  • Ticker Symbol: BCYC
  • Exchange: NASDAQ
  1. Reporting Context:
  • The financial data is presented as of the date January 13, 2025.
  • The report includes information related to common stock and American Depositary Shares.
  1. Units of Measurement:
  • Financials are reported in USD (United States Dollar) and shares, with a specific unit measure for price per share in USD.
  1. Contact Information:
  • Address: Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, GB CB21 6GS
  • Phone: +44 1223 261503
  1. Form Type:
  • The report is filed as an 8-K, indicating it is a current report that companies must file with the SEC to announce major events that shareholders should know about.
  1. Note on Shares:
  • The report indicates a breakdown of stock through explicit members for common stock and American Depositary Shares within the context of the financial report.

This information is essential for investors, analysts, and stakeholders who are examining Bicycle Therapeutics' financial health and corporate activities as of the reporting date.